Proceedings of the Workshop "Advanced Therapy Medicinal Products"

15-02-2013

This report summarises the presentations and discussions at the Workshop on “Advanced Therapy Medicinal Products”, held at the European Parliament in Brussels, on Wednesday 20 February 2013. The aim of the workshop was to exchange views on the opportunities and challenges related to advanced therapies for the future of healthcare. The workshop was hosted by MEP Ms Glenis WILLMOTT (S&D, UK) and MEP Mr Alojz PETERLE (EPP, SL), Co-chairs of the Health Working Group within the ENVI Committee.

This report summarises the presentations and discussions at the Workshop on “Advanced Therapy Medicinal Products”, held at the European Parliament in Brussels, on Wednesday 20 February 2013. The aim of the workshop was to exchange views on the opportunities and challenges related to advanced therapies for the future of healthcare. The workshop was hosted by MEP Ms Glenis WILLMOTT (S&D, UK) and MEP Mr Alojz PETERLE (EPP, SL), Co-chairs of the Health Working Group within the ENVI Committee.

Extern avdelning

Ms Sabine Jülicher, DG Health and Consumers, European Commission Prof. Stefaan Van Gool, Head of the Laboratory of Paediatric Immunology, University of Louvain (BE) Dr Jacques Mallet, Director of “Recherche Emérite” CNRS, Institute for Brain and Spinal Cord (ICM), Paris; Adjunct Professor at the University of California at San Francisco (UCSF); Member of the French Academy of Sciences (FR, US) Dr Monica Ensini, Scientific Director, European Organisation for Rare Diseases (EURORDIS) Dr Panos Kanavos, Reader in International Health Policy in the Department of Social Policy, London School of Economics (LSE) and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health (UK) Dr Maria Luisa Nolli, Founder and Chief Executive Officer of Areta International (IT) Dr Christian K. Schneider, Chair, Committee for Advanced Therapies (CAT), European Medicine Agency